NCT03334201

Brief Summary

The risk of developing cardiovascular diseases increases with aging largely due to age-related declines in the function of arteries (arterial dysfunction), which are influenced by common lifestyle factors such as consumption of a "Western" diet and lack of sufficient physical activity; thus, it is important to study how these factors interact to affect artery function. This study will determine whether changes to the gut microbiome (the collection of bacteria and other "microbes" living in the intestinal tract) with aging, Western diet consumption and aerobic exercise influence arterial function, and the biological pathways (mechanisms) involved. Specifically, the investigators will perform a randomized, single-blind, controlled feeding crossover study design (comparing Western diet to non-Western diet consumption) in young and older, exercising and non-exercising healthy adults to determine the time course effects (temporal association) of diet on the gut microbiome and arterial function. Overall, this research has potential to establish the gut microbiome as a possible target for treating/preventing age-related arterial dysfunction and reducing the risk of age-associated cardiovascular diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 1, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 7, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

March 15, 2018

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

October 28, 2021

Status Verified

October 1, 2021

Enrollment Period

3.8 years

First QC Date

November 1, 2017

Last Update Submit

October 27, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in the gut microbiome

    Sterile fecal swabs will be collected and analyzed using 16S rRNA sequencing

    7 days

  • Change in endothelial function

    Brachial artery flow-mediated dilation

    7 days

  • Change in arterial stiffness

    Carotid-femoral pulse wave velocity

    7 days

Study Arms (2)

Western diet first

OTHER

To receive Western diet controlled feeding first, followed by non-Western diet controlled feeding

Other: Western DietOther: Non-Western Diet

Non-Western diet first

OTHER

To receive non-Western diet controlled feeding first, followed by Western diet controlled feeding

Other: Western DietOther: Non-Western Diet

Interventions

high fat (40%), high sugar (25%) and low fiber (15g/day)

Non-Western diet firstWestern diet first

low fat (25%), low sugar (15%), high fiber (30g/day)

Non-Western diet firstWestern diet first

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-29 or 60-79 years
  • Participating in \< 30 min aerobic exercise \< 2x/wk for \>3 years OR \> 45 min vigorous aerobic exercise \> 4x/wk for \> 3 yrs
  • Currently consuming levels of dietary fat intake with the 40th-60th percentile of Americans based on the NHANES survey (29-37% calories from fat)
  • Healthy (no clinical disease)
  • Body mass index \< 30 kg/m2
  • Ankle-brachial blood pressure index \> 0.9
  • Total cholesterol \< 240 mg/dl
  • Fasting plasma glucose \< 110 mg/dl
  • Weight stable in the past 6 months

You may not qualify if:

  • Current or past (within 3 months of screening) use of dietary supplements, anti-inflammatory medications, drugs known to affect the gut microbiome (antibiotics, pre/probiotics, antifungals, antivirals, antiparasitics), or gastrointestinal-targeted drugs (proton pump inhibitors, H2 receptor antagonists, laxatives, antidiarrheal medications)
  • Current of past (within 5 years) smoking
  • Major change in health status in the last 6 months
  • Chronic clinical diseases (e.g., inflammatory bowl diseases, cardiovascular disease, diabetes, neurological disorders, dementia or other brain diseases of aging)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Boulder

Boulder, Colorado, 80309, United States

RECRUITING

MeSH Terms

Interventions

Diet, Western

Intervention Hierarchy (Ancestors)

DietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Douglas R Seals, PhD

    University of Colorado, Boulder

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kara Lubieniecki, MS

CONTACT

Vienna E Brunt, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Single-blind
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomized, single-blind crossover
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Distinguished Professor

Study Record Dates

First Submitted

November 1, 2017

First Posted

November 7, 2017

Study Start

March 15, 2018

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

October 28, 2021

Record last verified: 2021-10

Locations